Faculty Opinions recommendation of Chronic Administration of the N-Methyl-D-Aspartate Receptor Antagonist Ketamine Improves Rett Syndrome Phenotype.

Author(s):  
Laurent Villard ◽  
Jean-Christophe Roux
2016 ◽  
Vol 79 (9) ◽  
pp. 755-764 ◽  
Author(s):  
Annarita Patrizi ◽  
Nathalie Picard ◽  
Alex Joseph Simon ◽  
Georgia Gunner ◽  
Eleonora Centofante ◽  
...  

2007 ◽  
Vol 35 (8) ◽  
pp. 1350-1364 ◽  
Author(s):  
Chandra Prakash ◽  
Donghui Cui ◽  
Michael J. Potchoiba ◽  
Todd Butler

2011 ◽  
Vol 6 (4) ◽  
pp. 228
Author(s):  
José L Molinuevo ◽  

Two effective symptomatic therapies are available for Alzheimer’s disease: the cholinesterase inhibitors (ChEIs) and memantine, an N-methyl-D-aspartate receptor antagonist. Current data demonstrate that combination therapy with memantine and a ChEI produces symptomatic benefits in all domains of AD. The benefits of combination therapy are greater than those of ChEI monotherapy, are sustained long term and appear to increase with time.


2017 ◽  
Author(s):  
Masatsugu Ohgami ◽  
Nobuhiko Takai ◽  
Masahiko Watanabe ◽  
Koichi Ando ◽  
Akiko Uzawa ◽  
...  

1992 ◽  
Vol 26 (4) ◽  
pp. 205-209 ◽  
Author(s):  
Yuji Wada ◽  
Hidehiro Hasegawa ◽  
Mitsuhiko Nakamura ◽  
Nariyoshi Yamaguchi

Sign in / Sign up

Export Citation Format

Share Document